Literature DB >> 10091113

Serum progesterone in predicting pregnancy outcome after assisted reproductive technology.

M al-Ramahi1, S Perkins, P Claman.   

Abstract

PURPOSE: Our purpose was to determine whether serum progesterone predicts pregnancy outcome after superovulation.
METHODS: One hundred twenty-three consecutively pregnant patients were divided into three groups: group I, 55 patients following superovulation for assisted reproductive technologies; group II, 23 patients after correction of oligoovulation; and group III, 45 patients who conceived spontaneously. When beta-human chorionic gonadotropin was positive, progesterone was measured on the same serum sample. A serum progesterone level of 45 microns/L was set to differentiate between nonviable pregnancy and ongoing pregnancy.
RESULTS: In group I, zero (0%) of 38 ongoing pregnancies and 10 (59%) of 17 nonviable pregnancies were observed with a progesterone level of < 45 microns/L [14.2 ng/ml (P < 0.001)]. In group II, 4 (27%) of 15 ongoing pregnancies and 5 (63%) of 8 nonviable pregnancies had a progesterone level of < 45 microns/L (P = NS). In group III, 10 (42%) of 24 ongoing pregnancies and 15 (71%) of 21 nonviable pregnancies were observed with a progesterone level of < 45 microns/L (14.2 ng/ml) (P = NS).
CONCLUSIONS: A serum progesterone level of < 45 nM predicts nonviable pregnancy after superovulation for assisted reproductive technology.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10091113      PMCID: PMC3455210          DOI: 10.1023/a:1022523613267

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  7 in total

1.  Predicting pregnancy outcome after in vitro fertilization and embryo transfer using estradiol, progesterone, and human chorionic gonadotropin beta-subunit.

Authors:  T Yamashita; S Okamoto; A Thomas; V MacLachlan; D L Healy
Journal:  Fertil Steril       Date:  1989-02       Impact factor: 7.329

2.  The role of a single progesterone measurement in the diagnosis of early pregnancy failure and the prognosis of fetal viability.

Authors:  M A al-Sebai; C R Kingsland; M Diver; L Hipkin; I R McFadyen
Journal:  Br J Obstet Gynaecol       Date:  1995-05

3.  Serum progesterone and estradiol concentrations in the early diagnosis of ectopic pregnancy after in vitro fertilization-embryo transfer.

Authors:  M Bustillo; J J Stern; D King; C B Coulam
Journal:  Fertil Steril       Date:  1993-03       Impact factor: 7.329

4.  Relative operating characteristic analysis in reproductive medicine: comparison of progesterone and human chorionic gonadotropin doubling time as predictors of early gestational normalcy.

Authors:  J D Isaacs; N S Whitworth; B D Cowan
Journal:  Fertil Steril       Date:  1994-09       Impact factor: 7.329

5.  Single serum progesterone as a screen for ectopic pregnancy: exchanging specificity and sensitivity to obtain optimal test performance.

Authors:  M L McCord; D Muram; J E Buster; K L Arheart; T G Stovall; S A Carson
Journal:  Fertil Steril       Date:  1996-10       Impact factor: 7.329

6.  Early diagnosis of ectopic pregnancy using receiver-operator characteristic curves of serum progesterone concentrations.

Authors:  J J Stern; F Voss; C B Coulam
Journal:  Hum Reprod       Date:  1993-05       Impact factor: 6.918

7.  Does serologic evidence of remote Chlamydia trachomatis infection and its heat shock protein (CHSP 60) affect in vitro fertilization-embryo transfer outcome?

Authors:  P Claman; M N Amimi; R W Peeling; B Toye; P Jessamine
Journal:  Fertil Steril       Date:  1996-01       Impact factor: 7.329

  7 in total
  4 in total

1.  Early hormonal markers of pregnancy outcome after in vitro fertilization and embryo transfer.

Authors:  Francisco Carmona; Juan Balasch; Montserrat Creus; Francisco Fábregues; Roser Casamitjana; Salvadora Cívico; Ester Vidal; Josep M Calafell; Vicenta Moreno; Juan A Vanrell
Journal:  J Assist Reprod Genet       Date:  2003-12       Impact factor: 3.412

2.  The effectiveness of luteal phase support with cyclogest in ovarian stimulated intra uterine insemination cycles: A randomized controlled trial.

Authors:  Bibi Shahnaz Aali; Sakineh Ebrahimipour; Siavash Medhdizadeh
Journal:  Iran J Reprod Med       Date:  2013-04

3.  The efficacy and safety of luteal phase support with progesterone following ovarian stimulation and intrauterine insemination: A systematic review and meta-analysis.

Authors:  G Casarramona; T Lalmahomed; Chc Lemmen; Mjc Eijkemans; Fjm Broekmans; Aep Cantineau; Kce Drechsel
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-02       Impact factor: 6.055

4.  Early serum progesterone and prolactin analysis at day 9 of oocyte retrieval as a predictor of success in fresh ICSI cycles.

Authors:  Paulina A Santander Pérez; Álvaro P Ceschin; Daniela M P de Moraes; Lucileine K S N de Oliveira; Nathan I Ceschin; Nathan Ichikawa
Journal:  JBRA Assist Reprod       Date:  2018-06-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.